Innovation & intellectual property · 01/10/2024Updated: 10/17/2026 · 1 min read
U.S. Patent Office Grants Interim Extension to Treosulfan Patent
Summary
The United States Patent and Trademark Office has issued a certificate for a one-year interim extension of the term of U.S. Patent No. 7,199,162, which covers Treosulfan, a cancer treatment drug.
Original source language: Federal Register — Patent and Trademark OfficeOpen original release →